Drug Class
HIV-1 capsid inhibitor
Type
brand
Active Ingredient
lenacapavir
📋Overview
Sunlenca is a medication used in the management of HIV-1 infection. It belongs to a class of drugs known as capsid inhibitors, which interfere with the virus's ability to replicate within the body. Sunlenca is typically considered for individuals with limited treatment options due to resistance or intolerance to other HIV therapies. Its use is associated with efforts to control viral load and support immune function in affected individuals.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Sunlenca
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.